|

Tesamorelin Clinical Trials

1 actively recruiting trial

Pipeline

Phase 2: 1

Top Sponsors

  • Hudson Biotech1

Indications

  • Metabolic-Associated Steatotic Liver Disease1
  • Hepatic Steatosis1
  • Liver Disease1
  • Nonalcoholic Steatohepatitis1

Other1 trial

Tesamorelin for Reduction of Liver Fat in Adults With Fatty Liver Disease (Mock Study)
Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.